FDA Inspection 1133484 — Haupt Pharma Wolfratshausen GmbH

Haupt Pharma Wolfratshausen GmbH — FEI 3000310230

The FDA completed an inspection of Haupt Pharma Wolfratshausen GmbH on August 5, 2020 in Wolfratshausen. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 5, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Wolfratshausen (Germany)

Additional Details

Mutual Recognition Agreement (MRA)